https://pubmed.ncbi.nlm.nih.gov/24954503/
BTK inhibitors in chronic lymphocytic leukemia: a glimpse to the future
The treatment of chronic lymphocytic leukemia (CLL) with inhibitors targeting B cell receptor signaling and other survival mechanisms holds great promise....
chronic lymphocytic leukemiabtk inhibitors
https://pubchem.ncbi.nlm.nih.gov/bioassay/1795100
AID 1795100 - Bruton's Tyrosine Kinase (BTK) Inhibition Assay from US Patent US9556147: "Inhibitors...
BioAssay record AID 1795100 submitted by BindingDB: Bruton's Tyrosine Kinase (BTK) Inhibition Assay from US Patent US9556147: